{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:58:50Z","timestamp":1790866730365,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tehran University of Medical Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Research in Developmental Disabilities"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ridd.2011.10.001","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T01:05:27Z","timestamp":1322701527000},"page":"563-569","source":"Crossref","is-referenced-by-count":28,"title":["Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: Perspective from a developing country"],"prefix":"10.1016","volume":"33","author":[{"given":"Amir Hossein","family":"Memari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Ziaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Beygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouria","family":"Moshayedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Sadat","family":"Mirfazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ridd.2011.10.001_bib0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ridd.2010.02.007","article-title":"Treatment choices in autism spectrum disorder: The role of parental illness perceptions","volume":"31","author":"Al Anbar","year":"2010","journal-title":"Research in Developmental Disabilities"},{"issue":"4","key":"10.1016\/j.ridd.2011.10.001_bib0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/(SICI)1098-2779(1999)5:4<279::AID-MRDD5>3.0.CO;2-6","article-title":"Review of serotonergic agents and perseverative behavior in patients with developmental disabilities","volume":"5","author":"Aman","year":"1999","journal-title":"Mental Retardation and Developmental Disabilities Research Reviews"},{"issue":"5","key":"10.1016\/j.ridd.2011.10.001_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1025883612879","article-title":"Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio","volume":"33","author":"Aman","year":"2003","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/cap.2005.15.116","article-title":"Medication patterns in patients with autism: Temporal, regional, and demographic influences","volume":"15","author":"Aman","year":"2005","journal-title":"Journal of Child & Adolescent Psychopharmacology"},{"issue":"12","key":"10.1016\/j.ridd.2011.10.001_bib0025","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1097\/00004583-199512000-00018","article-title":"Psychotropic and anticonvulsant drugs in subjects with autism: Prevalence and patterns of use","volume":"34","author":"Aman","year":"1995","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"10.1016\/j.ridd.2011.10.001_bib0030","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/026988110201600113","article-title":"A systematic review of the use of atypical antipsychotics in autism","volume":"16","author":"Barnard","year":"2002","journal-title":"Journal of Psychopharmacology"},{"issue":"10","key":"10.1016\/j.ridd.2011.10.001_bib0040","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10803-010-1164-y","article-title":"Treatments for autism: Parental choices and perceptions of change","volume":"41","author":"Bowker","year":"2011","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"5","key":"10.1016\/j.ridd.2011.10.001_bib0045","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.pcl.2008.07.002","article-title":"Use of psychotropic medications in children with developmental disabilities","volume":"55","author":"Calles","year":"2008","journal-title":"Pediatric Clinics of North America"},{"issue":"10","key":"10.1016\/j.ridd.2011.10.001_bib0050","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.160.10.1817","article-title":"Racial disparity in the use of atypical antipsychotic medications among veterans","volume":"160","author":"Copeland","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.ridd.2011.10.001_bib0055","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ridd.2011.01.010","article-title":"Treating the cause of illness rather than the symptoms: Parental causal beliefs and treatment choices in autism spectrum disorder","volume":"32","author":"Dardennes","year":"2011","journal-title":"Research in Developmental Disabilities"},{"issue":"9","key":"10.1016\/j.ridd.2011.10.001_bib0060","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s10803-009-0750-3","article-title":"A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders","volume":"39","author":"Esbensen","year":"2009","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ridd.2004.12.002","article-title":"Internet survey of treatments used by parents of children with autism","volume":"27","author":"Green","year":"2006","journal-title":"Research in Developmental Disabilities"},{"issue":"3","key":"10.1016\/j.ridd.2011.10.001_bib0070","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.npp.1300627","article-title":"A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism","volume":"30","author":"Hollander","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0075","first-page":"CD005040","article-title":"Risperidone for autism spectrum disorder","author":"Jesner","year":"2007","journal-title":"Cochrane Database Systematic Reviews"},{"issue":"6","key":"10.1016\/j.ridd.2011.10.001_bib0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior","volume":"66","author":"King","year":"2009","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.ridd.2011.10.001_bib0085","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4088\/JCP.v67n0311","article-title":"Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability","volume":"67","author":"Kolevzon","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.ridd.2011.10.001_bib0090","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1176\/appi.ajp.159.4.567","article-title":"Racial disparities in antipsychotic prescription patterns for patients with schizophrenia","volume":"159","author":"Kuno","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-0179-3-21","article-title":"The impact of prescribed psychotropics on youth","volume":"3","author":"Lakhan","year":"2007","journal-title":"Clinical Practice and Epidemiology in Mental Health"},{"issue":"4","key":"10.1016\/j.ridd.2011.10.001_bib0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/104454602762599853","article-title":"Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina","volume":"12","author":"Langworthy-Lam","year":"2002","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.ridd.2011.10.001_bib0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","article-title":"Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders","volume":"24","author":"Lord","year":"1994","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"5","key":"10.1016\/j.ridd.2011.10.001_bib0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/00003495-200969050-00003","article-title":"The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism","volume":"69","author":"Malone","year":"2009","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ridd.2011.10.001_bib0115","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1542\/peds.2007-0984","article-title":"Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders","volume":"121","author":"Mandell","year":"2008","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.ridd.2011.10.001_bib0120","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder","volume":"48","author":"Marcus","year":"2009","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"7","key":"10.1016\/j.ridd.2011.10.001_bib0125","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00004583-199907000-00024","article-title":"Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use","volume":"38","author":"Martin","year":"1999","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.rasd.2010.04.004","article-title":"Psychotropic drug efficacy and side effects for persons with autism spectrum disorders","volume":"5","author":"Matson","year":"2011","journal-title":"Research in Autism Spectrum Disorders"},{"issue":"4","key":"10.1016\/j.ridd.2011.10.001_bib0135","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.rasd.2011.03.007","article-title":"A multinational study examining the cross cultural differences in reported symptoms of autism spectrum disorders: Israel, South Korea, the United Kingdom, and the United States of America","volume":"5","author":"Matson","year":"2011","journal-title":"Research in Autism Spectrum Disorders"},{"issue":"5","key":"10.1016\/j.ridd.2011.10.001_bib0140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4088\/JCP.v61n0105","article-title":"Racial variation in antidepressant treatment in a Medicaid population","volume":"61","author":"Melfi","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0215","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.rasd.2011.05.004","article-title":"Weight status in Iranian children with autism spectrum disorders: Investigation of underweight, overweight and obesity","volume":"6","author":"Memari","year":"2012","journal-title":"Research in Autism Spectrum Disorders"},{"issue":"5","key":"10.1016\/j.ridd.2011.10.001_bib0155","first-page":"1162","article-title":"Management of children with autism spectrum disorders","volume":"120","author":"Myers","year":"2007","journal-title":"AAP Policy"},{"issue":"3","key":"10.1016\/j.ridd.2011.10.001_bib0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/cap.2006.17303","article-title":"Medication use among children with autism spectrum disorders","volume":"17","author":"Oswald","year":"2007","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"6","key":"10.1016\/j.ridd.2011.10.001_bib0165","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ridd.2011.10.001_bib0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10803-006-0234-7","article-title":"Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Pandina","year":"2007","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1176\/appi.ps.56.1.31","article-title":"Psychopharmacology: Cross-cultural psychopharmacology: A current clinical perspective","volume":"56","author":"Pi","year":"2005","journal-title":"Psychiatric Services"},{"issue":"1","key":"10.1016\/j.ridd.2011.10.001_bib0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1172\/JCI32483","article-title":"Antipsychotics in the treatment of autism","volume":"118","author":"Posey","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.ridd.2011.10.001_bib0185","unstructured":"Rimland, B., & Edelson, M. (1999). The autism treatment evaluation checklist (ATEC). In (Vol. January 2011)."},{"issue":"3","key":"10.1016\/j.ridd.2011.10.001_bib0190","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10803-009-0878-1","article-title":"Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007\u20132008","volume":"40","author":"Rosenberg","year":"2010","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"3","key":"10.1016\/j.ridd.2011.10.001_bib0195","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1744-6171.2007.00112.x","article-title":"Risperidone approved for the treatment of serious behavioral problems in children with autism","volume":"20","author":"Scahill","year":"2007","journal-title":"Journal of Child and Adolescent Psychiatric Nursing: Official Publication of the Association of Child and Adolescent Psychiatric Nurses, Inc"},{"issue":"4","key":"10.1016\/j.ridd.2011.10.001_bib0200","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.chc.2008.06.002","article-title":"Pharmacotherapy of irritability in pervasive developmental disorders","volume":"17","author":"Stigler","year":"2008","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"issue":"6","key":"10.1016\/j.ridd.2011.10.001_bib0205","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s10803-006-0248-1","article-title":"Behaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autism","volume":"37","author":"Tsakanikos","year":"2007","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"4","key":"10.1016\/j.ridd.2011.10.001_bib0210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/cap.2005.15.671","article-title":"Treatment incidence and patterns in children and adolescents with autism spectrum disorders","volume":"15","author":"Witwer","year":"2005","journal-title":"Journal of Child & Adolescent Psychopharmacology"}],"container-title":["Research in Developmental Disabilities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422211003805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422211003805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T07:21:17Z","timestamp":1543389677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891422211003805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0891422211003805"],"URL":"https:\/\/doi.org\/10.1016\/j.ridd.2011.10.001","relation":{},"ISSN":["0891-4222"],"issn-type":[{"value":"0891-4222","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}